|
⚲
|
| Keyboard |
| Kalofonos Isabel
✚
|
|
|---|---|
| CIK # | 0001975163 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001975163] | |
| 4 | [0001975163] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kalofonos Isabel | |
| Crinetics Pharmaceuticals Inc | |
| ImmunoGen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2026-02-23 | Grant | 55,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-02-23 | Grant | 34,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-01-05 | Option exercise | 2,500 | $40.59 | 101,475 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Option exercise | 2,500 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-01-05 | Sell | 2,500 | $55.00 | 137,500 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2025-01-10 | Grant | 100,000 | $0.00 | |
|
ImmunoGen Inc IMGN
Restricted Stock Unit · derivative
|
2024-02-12 | Disposed to issuer | 47,375 | ||
|
ImmunoGen Inc IMGN
Restricted Stock Unit · derivative
|
2024-02-12 | Disposed to issuer | 19,458 | ||
|
ImmunoGen Inc IMGN
Stock Option (Right to Buy) · derivative
|
2024-02-12 | Disposed to issuer | 284,250 | ||
|
ImmunoGen Inc IMGN
Restricted Stock Unit · derivative
|
2024-02-01 | Grant | 19,458 | $0.00 | |
|
ImmunoGen Inc IMGN
Restricted Stock Unit · derivative
|
2023-04-28 | Grant | 47,375 | $0.00 | |
|
ImmunoGen Inc IMGN
Stock Option (Right to Buy) · derivative
|
2023-04-28 | Grant | 284,250 | $0.00 |